152 related articles for article (PubMed ID: 30518776)
1. Extracellular Protein Fibulin-7 and Its C-Terminal Fragment Have In Vivo Antiangiogenic Activity.
Ikeuchi T; de Vega S; Forcinito P; Doyle AD; Amaral J; Rodriguez IR; Arikawa-Hirasawa E; Yamada Y
Sci Rep; 2018 Dec; 8(1):17654. PubMed ID: 30518776
[TBL] [Abstract][Full Text] [Related]
2. A C-terminal fragment of fibulin-7 interacts with endothelial cells and inhibits their tube formation in culture.
de Vega S; Suzuki N; Nonaka R; Sasaki T; Forcinito P; Arikawa-Hirasawa E; Yamada Y
Arch Biochem Biophys; 2014 Mar; 545():148-53. PubMed ID: 24480309
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin-1.
de Vega S; Kondo A; Suzuki M; Arai H; Jiapaer S; Sabit H; Nakada M; Ikeuchi T; Ishijima M; Arikawa-Hirasawa E; Yamada Y; Okada Y
Int J Cancer; 2019 Oct; 145(8):2157-2169. PubMed ID: 30924128
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo.
Sarangi PP; Chakraborty P; Dash SP; Ikeuchi T; de Vega S; Ambatipudi K; Wahl L; Yamada Y
FASEB J; 2018 Sep; 32(9):4889-4898. PubMed ID: 29634368
[TBL] [Abstract][Full Text] [Related]
5. Identification of peptides derived from the C-terminal domain of fibulin-7 active for endothelial cell adhesion and tube formation disruption.
de Vega S; Hozumi K; Suzuki N; Nonaka R; Seo E; Takeda A; Ikeuchi T; Nomizu M; Yamada Y; Arikawa-Hirasawa E
Biopolymers; 2016 Mar; 106(2):184-195. PubMed ID: 26491858
[TBL] [Abstract][Full Text] [Related]
6. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
7. Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth.
Xie L; Palmsten K; MacDonald B; Kieran MW; Potenta S; Vong S; Kalluri R
Exp Biol Med (Maywood); 2008 Feb; 233(2):155-62. PubMed ID: 18222970
[TBL] [Abstract][Full Text] [Related]
8. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
[TBL] [Abstract][Full Text] [Related]
9. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.
Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW
J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561
[TBL] [Abstract][Full Text] [Related]
10. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
12. YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Xia Y; Song X; Li D; Ye T; Xu Y; Lin H; Meng N; Li G; Deng S; Zhang S; Liu L; Zhu Y; Zeng J; Lei Q; Pan Y; Wei Y; Zhao Y; Yu L
Sci Rep; 2014 Aug; 4():6031. PubMed ID: 25112436
[TBL] [Abstract][Full Text] [Related]
13. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
Huang SW; Lien JC; Kuo SC; Huang TF
Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
[TBL] [Abstract][Full Text] [Related]
14. Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition.
Dos Santos PK; Altei WF; Danilucci TM; Lino RLB; Pachane BC; Nunes ACC; Selistre-de-Araujo HS
Biochimie; 2020 Jul; 174():144-158. PubMed ID: 32360415
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
16. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
